Industry Supported Learning
Patricia Carney, MD
Director, Medical Affairs
Organon & Co.
Jersey City, New Jersey, United States
I have nothing relevant to disclose for this role and/or disclosures are not required to be reported for this non-CME activity.
Dena Goffman, MD (she/her/hers)
Professor, Women's Health in Obstetrics & Gynecology; Vice Chair, Quality & Patient Safety
New York Presbyterian, Columbia University Medical Center
New York, NY, United States
I have nothing relevant to disclose for this role and/or disclosures are not required to be reported for this non-CME activity.
Tori O'Daniel, MD, FACOG
Medical Director, OB Hospitalists and Women’s Services; Director of OSU Medical Student Clinical Rotation
Mercy Hospital
Oklahoma City, Oklahoma, United States
I have nothing relevant to disclose for this role and/or disclosures are not required to be reported for this non-CME activity.
This independent presentation is not part of the official program as planned by the SMFM Pregnancy Meeting™ Program Committee. The content of this session is not endorsed by or recommended by SMFM.
Description:
This course features an interactive discussion with adopters of the JADA System as part of their abnormal postpartum uterine bleeding and hemorrhage armamentarium. Dr. Goffman will lead the discussion that starts with a review of the JADA System indications for use and clinical evidence. Dr. O’Daniel will add to the discussion with case reviews from their experience with JADA and observed clinical outcomes, and best practices for implementation with their Labor and Delivery teams.